Evidence map›Paper›PMID 29769068›Full record

ArticleJournal of translational medicine2018

Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.

Julia Slotta-Huspenina, Enken Drecoll, Marcus Feith, Daniel Habermehl, Stephanie E Combs, Wilko Weichert, Marcus Bettstetter, Karen Becker, Rupert Langer

Abstract readPublished Erratum
In one paragraph

Article in Journal of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Julia Slotta-HuspeninaInstitute of Pathology, Technische Universität München, Trogerstrasse 18, 81675, Munich, Germany.
Enken DrecollInstitute of Pathology, Technische Universität München, Trogerstrasse 18, 81675, Munich, Germany.
Marcus FeithDepartment of Surgery, Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany.
Daniel HabermehlDepartment of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany.
Stephanie E CombsDepartment of Radiation Oncology, Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany.
Wilko WeichertInstitute of Pathology, Technische Universität München, Trogerstrasse 18, 81675, Munich, Germany.
Marcus BettstetterTeilgemeinschaftspraxis Molekularpathologie Südbayern, Giesinger Bahnhofplatz 2, 81539, Munich, Germany.
Karen BeckerInstitute of Pathology, Technische Universität München, Trogerstrasse 18, 81675, Munich, Germany.
Rupert LangerInstitute of Pathology, University of Bern, Murtenstrasse 31, 3008, Bern, Switzerland. rupert.langer@pathology.unibe.ch.ORCID 0000-0001-9491-3609

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following publication of the original article [1], the authors reported that for one of the authors, Stephanie E. Combs, the middle name was accidentally omitted. They also reported that for two of the authors, Daniel Habermehl and Stephanie E. Combs, two affiliations were accidentally omitted. In this Correction the incorrect and correct author name are shown and the two omitted affiliations are listed.

Identifiers

PMID29769068
PMCPMC5954453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.